1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Feline Atopic Dermatitis Drug Revenue 1.4 Market Analysis by Type 1.4.1 Global Feline Atopic Dermatitis Drug Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Corticosteroids 1.4.3 Antihistamines 1.4.4 Antibiotics 1.5 Market by Application 1.5.1 Global Feline Atopic Dermatitis Drug Market Share by Application: 2020 VS 2026 1.5.2 Veterinary Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Online Pharmacy 1.6 Coronavirus Disease 2019 (Covid-19): Feline Atopic Dermatitis Drug Industry Impact 1.6.1 How the Covid-19 is Affecting the Feline Atopic Dermatitis Drug Industry 1.6.1.1 Feline Atopic Dermatitis Drug Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Feline Atopic Dermatitis Drug Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Feline Atopic Dermatitis Drug Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Feline Atopic Dermatitis Drug Market Perspective (2015-2026) 2.2 Feline Atopic Dermatitis Drug Growth Trends by Regions 2.2.1 Feline Atopic Dermatitis Drug Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Feline Atopic Dermatitis Drug Historic Market Share by Regions (2015-2020) 2.2.3 Feline Atopic Dermatitis Drug Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Feline Atopic Dermatitis Drug Market Growth Strategy 2.3.6 Primary Interviews with Key Feline Atopic Dermatitis Drug Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Feline Atopic Dermatitis Drug Players by Market Size 3.1.1 Global Top Feline Atopic Dermatitis Drug Players by Revenue (2015-2020) 3.1.2 Global Feline Atopic Dermatitis Drug Revenue Market Share by Players (2015-2020) 3.1.3 Global Feline Atopic Dermatitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Feline Atopic Dermatitis Drug Market Concentration Ratio 3.2.1 Global Feline Atopic Dermatitis Drug Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Feline Atopic Dermatitis Drug Revenue in 2019 3.3 Feline Atopic Dermatitis Drug Key Players Head office and Area Served 3.4 Key Players Feline Atopic Dermatitis Drug Product Solution and Service 3.5 Date of Enter into Feline Atopic Dermatitis Drug Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Feline Atopic Dermatitis Drug Historic Market Size by Type (2015-2020) 4.2 Global Feline Atopic Dermatitis Drug Forecasted Market Size by Type (2021-2026) 5 Feline Atopic Dermatitis Drug Breakdown Data by Application (2015-2026) 5.1 Global Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) 5.2 Global Feline Atopic Dermatitis Drug Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Feline Atopic Dermatitis Drug Market Size (2015-2020) 6.2 Feline Atopic Dermatitis Drug Key Players in North America (2019-2020) 6.3 North America Feline Atopic Dermatitis Drug Market Size by Type (2015-2020) 6.4 North America Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) 7 Europe 7.1 Europe Feline Atopic Dermatitis Drug Market Size (2015-2020) 7.2 Feline Atopic Dermatitis Drug Key Players in Europe (2019-2020) 7.3 Europe Feline Atopic Dermatitis Drug Market Size by Type (2015-2020) 7.4 Europe Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Feline Atopic Dermatitis Drug Market Size (2015-2020) 8.2 Feline Atopic Dermatitis Drug Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Feline Atopic Dermatitis Drug Market Size by Type (2015-2020) 8.4 Asia-Pacific Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Bausch Health Companies 9.1.1 Bausch Health Companies Company Details 9.1.2 Bausch Health Companies Business Overview and Its Total Revenue 9.1.3 Bausch Health Companies Feline Atopic Dermatitis Drug Introduction 9.1.4 Bausch Health Companies Revenue in Feline Atopic Dermatitis Drug Business (2015-2020)) 9.1.5 Bausch Health Companies Recent Development 9.2 Bayer 9.2.1 Bayer Company Details 9.2.2 Bayer Business Overview and Its Total Revenue 9.2.3 Bayer Feline Atopic Dermatitis Drug Introduction 9.2.4 Bayer Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) 9.2.5 Bayer Recent Development 9.3 Pfizer 9.3.1 Pfizer Company Details 9.3.2 Pfizer Business Overview and Its Total Revenue 9.3.3 Pfizer Feline Atopic Dermatitis Drug Introduction 9.3.4 Pfizer Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) 9.3.5 Pfizer Recent Development 9.4 Novartis 9.4.1 Novartis Company Details 9.4.2 Novartis Business Overview and Its Total Revenue 9.4.3 Novartis Feline Atopic Dermatitis Drug Introduction 9.4.4 Novartis Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) 9.4.5 Novartis Recent Development 9.5 Sanofi 9.5.1 Sanofi Company Details 9.5.2 Sanofi Business Overview and Its Total Revenue 9.5.3 Sanofi Feline Atopic Dermatitis Drug Introduction 9.5.4 Sanofi Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) 9.5.5 Sanofi Recent Development 9.6 Eli Lily 9.6.1 Eli Lily Company Details 9.6.2 Eli Lily Business Overview and Its Total Revenue 9.6.3 Eli Lily Feline Atopic Dermatitis Drug Introduction 9.6.4 Eli Lily Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) 9.6.5 Eli Lily Recent Development 9.7 Bristol-Myers Squibb 9.7.1 Bristol-Myers Squibb Company Details 9.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 9.7.3 Bristol-Myers Squibb Feline Atopic Dermatitis Drug Introduction 9.7.4 Bristol-Myers Squibb Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) 9.7.5 Bristol-Myers Squibb Recent Development 9.8 C. H. Boehringer Sohn 9.8.1 C. H. Boehringer Sohn Company Details 9.8.2 C. H. Boehringer Sohn Business Overview and Its Total Revenue 9.8.3 C. H. Boehringer Sohn Feline Atopic Dermatitis Drug Introduction 9.8.4 C. H. Boehringer Sohn Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) 9.8.5 C. H. Boehringer Sohn Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Feline Atopic Dermatitis Drug Key Market Segments Table 2. Key Players Covered: Ranking by Feline Atopic Dermatitis Drug Revenue Table 3. Ranking of Global Top Feline Atopic Dermatitis Drug Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Feline Atopic Dermatitis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Corticosteroids Table 6. Key Players of Antihistamines Table 7. Key Players of Antibiotics Table 8. COVID-19 Impact Global Market: (Four Feline Atopic Dermatitis Drug Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Feline Atopic Dermatitis Drug Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Feline Atopic Dermatitis Drug Players to Combat Covid-19 Impact Table 13. Global Feline Atopic Dermatitis Drug Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Feline Atopic Dermatitis Drug Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Feline Atopic Dermatitis Drug Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Feline Atopic Dermatitis Drug Market Share by Regions (2015-2020) Table 17. Global Feline Atopic Dermatitis Drug Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Feline Atopic Dermatitis Drug Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Feline Atopic Dermatitis Drug Market Growth Strategy Table 23. Main Points Interviewed from Key Feline Atopic Dermatitis Drug Players Table 24. Global Feline Atopic Dermatitis Drug Revenue by Players (2015-2020) (Million US$) Table 25. Global Feline Atopic Dermatitis Drug Market Share by Players (2015-2020) Table 26. Global Top Feline Atopic Dermatitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Feline Atopic Dermatitis Drug as of 2019) Table 27. Global Feline Atopic Dermatitis Drug by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Feline Atopic Dermatitis Drug Product Solution and Service Table 30. Date of Enter into Feline Atopic Dermatitis Drug Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Feline Atopic Dermatitis Drug Market Size by Type (2015-2020) (Million US$) Table 33. Global Feline Atopic Dermatitis Drug Market Size Share by Type (2015-2020) Table 34. Global Feline Atopic Dermatitis Drug Revenue Market Share by Type (2021-2026) Table 35. Global Feline Atopic Dermatitis Drug Market Size Share by Application (2015-2020) Table 36. Global Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) (Million US$) Table 37. Global Feline Atopic Dermatitis Drug Market Size Share by Application (2021-2026) Table 38. North America Key Players Feline Atopic Dermatitis Drug Revenue (2019-2020) (Million US$) Table 39. North America Key Players Feline Atopic Dermatitis Drug Market Share (2019-2020) Table 40. North America Feline Atopic Dermatitis Drug Market Size by Type (2015-2020) (Million US$) Table 41. North America Feline Atopic Dermatitis Drug Market Share by Type (2015-2020) Table 42. North America Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) (Million US$) Table 43. North America Feline Atopic Dermatitis Drug Market Share by Application (2015-2020) Table 44. Europe Key Players Feline Atopic Dermatitis Drug Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Feline Atopic Dermatitis Drug Market Share (2019-2020) Table 46. Europe Feline Atopic Dermatitis Drug Market Size by Type (2015-2020) (Million US$) Table 47. Europe Feline Atopic Dermatitis Drug Market Share by Type (2015-2020) Table 48. Europe Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) (Million US$) Table 49. Europe Feline Atopic Dermatitis Drug Market Share by Application (2015-2020) Table 50. Asia-Pacific Key Players Feline Atopic Dermatitis Drug Revenue (2019-2020) (Million US$) Table 51. Asia-Pacific Key Players Feline Atopic Dermatitis Drug Market Share (2019-2020) Table 52. Asia-Pacific Feline Atopic Dermatitis Drug Market Size by Type (2015-2020) (Million US$) Table 53. Asia-Pacific Feline Atopic Dermatitis Drug Market Share by Type (2015-2020) Table 54. Asia-Pacific Feline Atopic Dermatitis Drug Market Size by Application (2015-2020) (Million US$) Table 55. Asia-Pacific Feline Atopic Dermatitis Drug Market Share by Application (2015-2020) Table 56. Bausch Health Companies Company Details Table 57. Bausch Health Companies Business Overview Table 58. Bausch Health Companies Product Table 59. Bausch Health Companies Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 60. Bausch Health Companies Recent Development Table 61. Bayer Company Details Table 62. Bayer Business Overview Table 63. Bayer Product Table 64. Bayer Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 65. Bayer Recent Development Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Product Table 69. Pfizer Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 70. Pfizer Recent Development Table 71. Novartis Company Details Table 72. Novartis Business Overview Table 73. Novartis Product Table 74. Novartis Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 75. Novartis Recent Development Table 76. Sanofi Company Details Table 77. Sanofi Business Overview Table 78. Sanofi Product Table 79. Sanofi Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 80. Sanofi Recent Development Table 81. Eli Lily Company Details Table 82. Eli Lily Business Overview Table 83. Eli Lily Product Table 84. Eli Lily Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 85. Eli Lily Recent Development Table 86. Bristol-Myers Squibb Company Details Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Product Table 89. Bristol-Myers Squibb Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 90. Bristol-Myers Squibb Recent Development Table 91. C. H. Boehringer Sohn Business Overview Table 92. C. H. Boehringer Sohn Product Table 93. C. H. Boehringer Sohn Company Details Table 94. C. H. Boehringer Sohn Revenue in Feline Atopic Dermatitis Drug Business (2015-2020) (Million US$) Table 95. C. H. Boehringer Sohn Recent Development Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global Feline Atopic Dermatitis Drug Market Share by Type: 2020 VS 2026 Figure 2. Corticosteroids Features Figure 3. Antihistamines Features Figure 4. Antibiotics Features Figure 5. Global Feline Atopic Dermatitis Drug Market Share by Application: 2020 VS 2026 Figure 6. Veterinary Pharmacy Case Studies Figure 7. Retail Pharmacy Case Studies Figure 8. Online Pharmacy Case Studies Figure 9. Feline Atopic Dermatitis Drug Report Years Considered Figure 10. Global Feline Atopic Dermatitis Drug Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Feline Atopic Dermatitis Drug Market Share by Regions: 2020 VS 2026 Figure 12. Global Feline Atopic Dermatitis Drug Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Feline Atopic Dermatitis Drug Market Share by Players in 2019 Figure 15. Global Top Feline Atopic Dermatitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Feline Atopic Dermatitis Drug as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Feline Atopic Dermatitis Drug Revenue in 2019 Figure 17. North America Feline Atopic Dermatitis Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Feline Atopic Dermatitis Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Asia-Pacific Feline Atopic Dermatitis Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 21. Bausch Health Companies Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 22. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Bayer Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Pfizer Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Novartis Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Sanofi Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 30. Eli Lily Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Eli Lily Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 32. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Bristol-Myers Squibb Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 34. C. H. Boehringer Sohn Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. C. H. Boehringer Sohn Revenue Growth Rate in Feline Atopic Dermatitis Drug Business (2015-2020) Figure 36. Bottom-up and Top-down Approaches for This Report Figure 37. Data Triangulation Figure 38. Key Executives Interviewed

Bausch Health Companies Bayer Pfizer Novartis Sanofi Eli Lily Bristol-Myers Squibb C. H. Boehringer Sohn